Purification, characterization and in vivo studies of salmon heparin
Abstract Heparin was purified from gills and intestines from farmed Atlantic salmon (Salmo salar). Heparin activity was determined after size exclusion chromatography in the molecular weight range from above 8,000 to near 1,500. A specific activity of 110.1 antifactor Xa units/mg was measured in the...
Gespeichert in:
Veröffentlicht in: | Thrombosis research 2010-12, Vol.126 (6), p.e409-e417 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e417 |
---|---|
container_issue | 6 |
container_start_page | e409 |
container_title | Thrombosis research |
container_volume | 126 |
creator | Flengsrud, Ragnar Larsen, Mette Lie Ødegaard, Ole Rasmus |
description | Abstract Heparin was purified from gills and intestines from farmed Atlantic salmon (Salmo salar). Heparin activity was determined after size exclusion chromatography in the molecular weight range from above 8,000 to near 1,500. A specific activity of 110.1 antifactor Xa units/mg was measured in the less than 3,500 molecular weight fraction while 136.8 antifactor Xa units/mg was detected in a 8,000-3,500 molecular weight fraction. The presence of high affinity salmon heparin was demonstrated by using chromatography on antithrombin-Sepharose. Heparin with molecular weights lower than 3,500 was found both in high and low affinity fractions. NMR-analysis detected N- and O-sulfated oligosaccharides essential for heparin activity. The amount of salmon heparin with molecular weight lower than 8,000 varied from 12% to almost 100%. The factors determining this variation is not known, but appears to reside in the fish at the time of slaughter. The in vivo effect of salmon heparin was tested in rabbits using dalteparin as control. Salmon heparin activity was recovered in plasma samples expressed as antifactor Xa activity after intravenous administration. Based on a small number of samples and animals, the results indicate that in vivo half-life time of salmon heparin was higher than that of dalteparin. |
doi_str_mv | 10.1016/j.thromres.2010.07.004 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_815966681</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0049384810003944</els_id><sourcerecordid>815966681</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-7a0593db5f7a694e5a52030ca99dcb48df14fe9ceb346e45f3e2cd2d50c76e123</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhi0Earcff6HKjQtZxl9xfEGgQgGpUiu1PVtee6L1ksSLnaxUfn293ZYDF04jvfPOjOZ5CbmgsKRAm4-b5bROcUiYlwyKCGoJIN6QBW2VrplQ7C1ZFEXXvBXtMTnJeQNAFdXyiBwz0FxJxhfk6-2cQhecnUIcP1RubZN1E6bw51mp7OirMFa7sItVnmYfMFexq7Lth9Jd49amMJ6Rd53tM56_1FPycPXt_vJHfX3z_efll-vaCcamWlmQmvuV7JRttEBpJQMOzmrt3Uq0vqOiQ-1wxUWDQnYcmfPMS3CqQcr4KXl_2LtN8feMeTJDyA773o4Y52xaKnXTNC0tzubgdCnmnLAz2xQGmx4NBbMHaDbmFaDZAzSgTMFVBi9eTsyrAf3fsVdixfD5YMDy6C5gMtkFHB36kNBNxsfw_xuf_lnh-jCWDPpf-Ih5E-c0FoyGmswMmLt9jPsUKQBwLQR_AlL6mvc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>815966681</pqid></control><display><type>article</type><title>Purification, characterization and in vivo studies of salmon heparin</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Flengsrud, Ragnar ; Larsen, Mette Lie ; Ødegaard, Ole Rasmus</creator><creatorcontrib>Flengsrud, Ragnar ; Larsen, Mette Lie ; Ødegaard, Ole Rasmus</creatorcontrib><description>Abstract Heparin was purified from gills and intestines from farmed Atlantic salmon (Salmo salar). Heparin activity was determined after size exclusion chromatography in the molecular weight range from above 8,000 to near 1,500. A specific activity of 110.1 antifactor Xa units/mg was measured in the less than 3,500 molecular weight fraction while 136.8 antifactor Xa units/mg was detected in a 8,000-3,500 molecular weight fraction. The presence of high affinity salmon heparin was demonstrated by using chromatography on antithrombin-Sepharose. Heparin with molecular weights lower than 3,500 was found both in high and low affinity fractions. NMR-analysis detected N- and O-sulfated oligosaccharides essential for heparin activity. The amount of salmon heparin with molecular weight lower than 8,000 varied from 12% to almost 100%. The factors determining this variation is not known, but appears to reside in the fish at the time of slaughter. The in vivo effect of salmon heparin was tested in rabbits using dalteparin as control. Salmon heparin activity was recovered in plasma samples expressed as antifactor Xa activity after intravenous administration. Based on a small number of samples and animals, the results indicate that in vivo half-life time of salmon heparin was higher than that of dalteparin.</description><identifier>ISSN: 0049-3848</identifier><identifier>EISSN: 1879-2472</identifier><identifier>DOI: 10.1016/j.thromres.2010.07.004</identifier><identifier>PMID: 20937523</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Animals ; Anticoagulants - chemistry ; Anticoagulants - isolation & purification ; Anticoagulants - pharmacology ; Antithrombin binding ; Cattle ; Chromatography, Gel ; Female ; Gills ; Gills - chemistry ; Hematology, Oncology and Palliative Medicine ; Heparin ; Heparin, Low-Molecular-Weight - chemistry ; Heparin, Low-Molecular-Weight - isolation & purification ; Heparin, Low-Molecular-Weight - pharmacology ; Humans ; Intestines ; Intestines - chemistry ; Low molecular weight heparin ; Molecular Weight ; Rabbits ; Salmo salar - metabolism ; Salmon</subject><ispartof>Thrombosis research, 2010-12, Vol.126 (6), p.e409-e417</ispartof><rights>Elsevier Ltd</rights><rights>2010 Elsevier Ltd</rights><rights>Copyright © 2010 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c422t-7a0593db5f7a694e5a52030ca99dcb48df14fe9ceb346e45f3e2cd2d50c76e123</citedby><cites>FETCH-LOGICAL-c422t-7a0593db5f7a694e5a52030ca99dcb48df14fe9ceb346e45f3e2cd2d50c76e123</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.thromres.2010.07.004$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20937523$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Flengsrud, Ragnar</creatorcontrib><creatorcontrib>Larsen, Mette Lie</creatorcontrib><creatorcontrib>Ødegaard, Ole Rasmus</creatorcontrib><title>Purification, characterization and in vivo studies of salmon heparin</title><title>Thrombosis research</title><addtitle>Thromb Res</addtitle><description>Abstract Heparin was purified from gills and intestines from farmed Atlantic salmon (Salmo salar). Heparin activity was determined after size exclusion chromatography in the molecular weight range from above 8,000 to near 1,500. A specific activity of 110.1 antifactor Xa units/mg was measured in the less than 3,500 molecular weight fraction while 136.8 antifactor Xa units/mg was detected in a 8,000-3,500 molecular weight fraction. The presence of high affinity salmon heparin was demonstrated by using chromatography on antithrombin-Sepharose. Heparin with molecular weights lower than 3,500 was found both in high and low affinity fractions. NMR-analysis detected N- and O-sulfated oligosaccharides essential for heparin activity. The amount of salmon heparin with molecular weight lower than 8,000 varied from 12% to almost 100%. The factors determining this variation is not known, but appears to reside in the fish at the time of slaughter. The in vivo effect of salmon heparin was tested in rabbits using dalteparin as control. Salmon heparin activity was recovered in plasma samples expressed as antifactor Xa activity after intravenous administration. Based on a small number of samples and animals, the results indicate that in vivo half-life time of salmon heparin was higher than that of dalteparin.</description><subject>Animals</subject><subject>Anticoagulants - chemistry</subject><subject>Anticoagulants - isolation & purification</subject><subject>Anticoagulants - pharmacology</subject><subject>Antithrombin binding</subject><subject>Cattle</subject><subject>Chromatography, Gel</subject><subject>Female</subject><subject>Gills</subject><subject>Gills - chemistry</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Heparin</subject><subject>Heparin, Low-Molecular-Weight - chemistry</subject><subject>Heparin, Low-Molecular-Weight - isolation & purification</subject><subject>Heparin, Low-Molecular-Weight - pharmacology</subject><subject>Humans</subject><subject>Intestines</subject><subject>Intestines - chemistry</subject><subject>Low molecular weight heparin</subject><subject>Molecular Weight</subject><subject>Rabbits</subject><subject>Salmo salar - metabolism</subject><subject>Salmon</subject><issn>0049-3848</issn><issn>1879-2472</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1v1DAQhi0Earcff6HKjQtZxl9xfEGgQgGpUiu1PVtee6L1ksSLnaxUfn293ZYDF04jvfPOjOZ5CbmgsKRAm4-b5bROcUiYlwyKCGoJIN6QBW2VrplQ7C1ZFEXXvBXtMTnJeQNAFdXyiBwz0FxJxhfk6-2cQhecnUIcP1RubZN1E6bw51mp7OirMFa7sItVnmYfMFexq7Lth9Jd49amMJ6Rd53tM56_1FPycPXt_vJHfX3z_efll-vaCcamWlmQmvuV7JRttEBpJQMOzmrt3Uq0vqOiQ-1wxUWDQnYcmfPMS3CqQcr4KXl_2LtN8feMeTJDyA773o4Y52xaKnXTNC0tzubgdCnmnLAz2xQGmx4NBbMHaDbmFaDZAzSgTMFVBi9eTsyrAf3fsVdixfD5YMDy6C5gMtkFHB36kNBNxsfw_xuf_lnh-jCWDPpf-Ih5E-c0FoyGmswMmLt9jPsUKQBwLQR_AlL6mvc</recordid><startdate>20101201</startdate><enddate>20101201</enddate><creator>Flengsrud, Ragnar</creator><creator>Larsen, Mette Lie</creator><creator>Ødegaard, Ole Rasmus</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20101201</creationdate><title>Purification, characterization and in vivo studies of salmon heparin</title><author>Flengsrud, Ragnar ; Larsen, Mette Lie ; Ødegaard, Ole Rasmus</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-7a0593db5f7a694e5a52030ca99dcb48df14fe9ceb346e45f3e2cd2d50c76e123</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Animals</topic><topic>Anticoagulants - chemistry</topic><topic>Anticoagulants - isolation & purification</topic><topic>Anticoagulants - pharmacology</topic><topic>Antithrombin binding</topic><topic>Cattle</topic><topic>Chromatography, Gel</topic><topic>Female</topic><topic>Gills</topic><topic>Gills - chemistry</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Heparin</topic><topic>Heparin, Low-Molecular-Weight - chemistry</topic><topic>Heparin, Low-Molecular-Weight - isolation & purification</topic><topic>Heparin, Low-Molecular-Weight - pharmacology</topic><topic>Humans</topic><topic>Intestines</topic><topic>Intestines - chemistry</topic><topic>Low molecular weight heparin</topic><topic>Molecular Weight</topic><topic>Rabbits</topic><topic>Salmo salar - metabolism</topic><topic>Salmon</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Flengsrud, Ragnar</creatorcontrib><creatorcontrib>Larsen, Mette Lie</creatorcontrib><creatorcontrib>Ødegaard, Ole Rasmus</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Thrombosis research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Flengsrud, Ragnar</au><au>Larsen, Mette Lie</au><au>Ødegaard, Ole Rasmus</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Purification, characterization and in vivo studies of salmon heparin</atitle><jtitle>Thrombosis research</jtitle><addtitle>Thromb Res</addtitle><date>2010-12-01</date><risdate>2010</risdate><volume>126</volume><issue>6</issue><spage>e409</spage><epage>e417</epage><pages>e409-e417</pages><issn>0049-3848</issn><eissn>1879-2472</eissn><abstract>Abstract Heparin was purified from gills and intestines from farmed Atlantic salmon (Salmo salar). Heparin activity was determined after size exclusion chromatography in the molecular weight range from above 8,000 to near 1,500. A specific activity of 110.1 antifactor Xa units/mg was measured in the less than 3,500 molecular weight fraction while 136.8 antifactor Xa units/mg was detected in a 8,000-3,500 molecular weight fraction. The presence of high affinity salmon heparin was demonstrated by using chromatography on antithrombin-Sepharose. Heparin with molecular weights lower than 3,500 was found both in high and low affinity fractions. NMR-analysis detected N- and O-sulfated oligosaccharides essential for heparin activity. The amount of salmon heparin with molecular weight lower than 8,000 varied from 12% to almost 100%. The factors determining this variation is not known, but appears to reside in the fish at the time of slaughter. The in vivo effect of salmon heparin was tested in rabbits using dalteparin as control. Salmon heparin activity was recovered in plasma samples expressed as antifactor Xa activity after intravenous administration. Based on a small number of samples and animals, the results indicate that in vivo half-life time of salmon heparin was higher than that of dalteparin.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>20937523</pmid><doi>10.1016/j.thromres.2010.07.004</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0049-3848 |
ispartof | Thrombosis research, 2010-12, Vol.126 (6), p.e409-e417 |
issn | 0049-3848 1879-2472 |
language | eng |
recordid | cdi_proquest_miscellaneous_815966681 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Animals Anticoagulants - chemistry Anticoagulants - isolation & purification Anticoagulants - pharmacology Antithrombin binding Cattle Chromatography, Gel Female Gills Gills - chemistry Hematology, Oncology and Palliative Medicine Heparin Heparin, Low-Molecular-Weight - chemistry Heparin, Low-Molecular-Weight - isolation & purification Heparin, Low-Molecular-Weight - pharmacology Humans Intestines Intestines - chemistry Low molecular weight heparin Molecular Weight Rabbits Salmo salar - metabolism Salmon |
title | Purification, characterization and in vivo studies of salmon heparin |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T10%3A19%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Purification,%20characterization%20and%20in%20vivo%20studies%20of%20salmon%20heparin&rft.jtitle=Thrombosis%20research&rft.au=Flengsrud,%20Ragnar&rft.date=2010-12-01&rft.volume=126&rft.issue=6&rft.spage=e409&rft.epage=e417&rft.pages=e409-e417&rft.issn=0049-3848&rft.eissn=1879-2472&rft_id=info:doi/10.1016/j.thromres.2010.07.004&rft_dat=%3Cproquest_cross%3E815966681%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=815966681&rft_id=info:pmid/20937523&rft_els_id=S0049384810003944&rfr_iscdi=true |